Skip to content Skip to footer
Subscribe Now

CXO TALKS

CXO Talks: Cary Claiborne from Adial Pharmaceuticals in a Stimulating Dialogue Exchange with PharmaShots
Welcome to the sixth episode of CXO Talks, featuring Cary Claiborne, CEO of Adial Pharmaceuticals a clinical-stage biopharmaceutical company dedicated to developing therapies for the treatment and prevention of addiction and related disorders.  Taking a walk down memory lane, Cary shares the inspiration behind founding Adial Pharmaceuticals. He recounts how an early study at the…
December 9, 2024
CXO Talks: Jed Litwiniuk & Uwe Tigör from Auxilius Pharma in a Riveting Dialogue Exchange with PharmaShots
In this fifth episode of our recently launched CXO Talks, we spoke with a distinguished panel of speakers from Auxilius Pharma, Jed Litwiniuk, the CEO, and Uwe Tigör, the CMO of the company. Auxilius Pharma is an emerging specialized pharma company aimed at developing, optimizing, and delivering well-established medications internationally.   Jed & Uwe walked memory…
November 11, 2024
CXO Talks: Rashmi Gurnani from AKT Health Analytics in a Riveting Dialogue Exchange with PharmaShots
In the fourth reprise of our recently launched Complimentary Exclusive Video Interview, we have Rashmi Gurnani CEO of AKT Health Analytics. Rashmi sheds light on AKT’s distributor partnership with Certara, known for delivering global drug development solutions to pharmaceutical companies and CROs.  While discussing AKT’s role in assisting the US clients with Japan’s PMDA’s approval,…
October 14, 2024
CXO Talks: Jonathan Usuka Chief Business Officer at Sapient, in a Stimulating Conversation with PharmaShots
Introducing the third installment of our recently launched Complimentary Exclusive Video Interview. Jonathan Usuka, Chief Business Officer at Sapient, highlighted Sapient’s high throughput proteomics and metabolomics capabilities to generate multi-omics data and the analytical power to transcend the genome to achieve robust biological discoveries in expediting clinical studies. By leveraging Sapient's real-world data asset, the…
September 9, 2024
CXO Talks: David A. Dodd, Chairman President and CEO of GeoVax Labs Inc. in a riveting conversation with PharmaShots
With great zeal, PharmaShots began an Exclusive Video Interview series for C-suites. An innovative idea to bring thought leaders of the industry, our Exclusive Video Interview offering is a noble initiative by PharmaShots to capture the developments of leading companies. As a part of offering, PharmaShots will be publishing exclusive video interviews every second Monday…
July 8, 2024
Spotlight Interview: Moreno Perugini in a Candid Conversation with PharmaShots
Following the Reuters Events Pharma USA 2024, PharmaShots brings an engaging conversation with Moreno Perugini, President, of Néstle Health Science. Moreno begins the conversation by highlighting Néstle’s journey to become a full-fledged pharma company through a series of acquisitions and deals.   Moreno recalls Néstle’s transitioning into a pharmaceutical company when the company got the rights for Zenpep,…
April 15, 2024
Spotlight Interview: David A. Dodd, CEO at GeoVax Labs, in an Engaging Conversation with PharmaShots
PharmaShots’ Spotlight offers a unique platform for biopharma, life sciences, and healthcare companies, allowing them to connect with their target audiences and like-minded people.  This week at the Spotlight, we had a riveting discussion with David A. Dodd, Chairman, President & CEO, at GeoVax Labs.  David eloquently highlighted GeoVax’s extraordinary journey over the years from…
February 26, 2024
Spotlight Interview: David Esposito CEO at ONL Therapeutics in a Stimulating Conversation with PharmaShots
“Spotlight-Company of the Month” offers a unique platform for biopharma, life sciences, and healthcare companies, allowing them to connect with their target audiences and like-minded people.  This month at PharmaShots’ Spotlight, we had an opportunity to engage in conversation with David Esposito CEO at ONL Therapeutics.  David discusses the company's lead candidate ONL1204, which is…
February 19, 2024
Load more